Literature DB >> 26244398

Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?

Jacomien Aleman1, Guido E L van den Berk, Eric J F Franssen, Carola W H de Fijter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26244398     DOI： 10.1097/QAD.0000000000000733

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

Review 1.  Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.

Authors:  Dario Cattaneo; Cristina Gervasoni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

2.  Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data.

Authors:  Filiz Akyüz; Bilger Çavuş; Nihan Nizam; Suut Göktürk; Bülent Baran; Halil Yazıcı; Sami Evirgen; Ümit Akyüz; Tuba Öbekli; Çetin Karaca; Kadir Demir; Fatih Beşışık; Sabahattin Kaymakoğlu
Journal:  Clin Exp Hepatol       Date:  2022-03-23

Review 3.  Pharmacotherapeutic options for kidney disease in HIV positive patients.

Authors:  Anam Tariq; Hannah Kim; Hashim Abbas; Gregory M Lucas; Mohamed G Atta
Journal:  Expert Opin Pharmacother       Date:  2020-09-21       Impact factor: 4.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.